Literature DB >> 32712858

Understanding the Role of Inflammasomes in Rheumatoid Arthritis.

Rashita Makkar1, Tapan Behl2, Simona Bungau3, Arun Kumar1, Sandeep Arora1.   

Abstract

Inflammasomes are the molecular pathways that activate upon conditions of infection or stress and trigger the activation and maturation of inflammatory cytokines. Immune reactions in conjugation with inflammatory processes play a pivotal role in developing innumerable diseases. An over reactive immune system fabricates many allergic and hypersensitive reactions in response to autoantibodies activated against modified self-epitopes and similar molecules. Rheumatoid arthritis (RA) is a complex autoimmune inflammatory disorder commencing with inflammation in small joints like hands, knees, and wrist eventually entrapping larger joints such as spine. The formation of autoantibodies called rheumatoid factor (RF) and citrullinated proteins against immunoglobulin G symbolizes autoimmune nature of the disease. The presence of autoantibodies embarks principal diagnostic hallmark of the disease. With the advancement of technology, the therapeutic approach is also advancing. A new era of molecules, namely inflammasomes, are activated upon infection or in response to stress and trigger the activation of various proinflammatory cytokines such interleukins which engage in the defense mechanism of the innate immunity. Robust linking among the activity of dysregulated inflammasomes and the heritable acquired inflammatory diseases and disorders emphasizes the significance of this pathway in altering the immune responses. The current review highlights the functioning of inflammasomes and their possible role in disease dysregulation.

Entities:  

Keywords:  CARD; NLR family; inflammasomes; innate immunity; pannus formations; rheumatoid arthritis

Mesh:

Substances:

Year:  2020        PMID: 32712858     DOI: 10.1007/s10753-020-01301-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  93 in total

1.  Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis.

Authors:  Alf Kastbom; Lisbeth Ärlestig; Solbritt Rantapää-Dahlqvist
Journal:  J Rheumatol       Date:  2015-07-15       Impact factor: 4.666

Review 2.  Pathophysiology of rheumatoid arthritis.

Authors:  Faye A H Cooles; John D Isaacs
Journal:  Curr Opin Rheumatol       Date:  2011-05       Impact factor: 5.006

3.  Oxidative stress in patients with rheumatoid arthritis.

Authors:  Adolfo García-González; Ramón Gaxiola-Robles; Tania Zenteno-Savín
Journal:  Rev Invest Clin       Date:  2015 Jan-Feb       Impact factor: 1.451

4.  The shaping of modern human immune systems by multiregional admixture with archaic humans.

Authors:  Laurent Abi-Rached; Matthew J Jobin; Subhash Kulkarni; Alasdair McWhinnie; Klara Dalva; Loren Gragert; Farbod Babrzadeh; Baback Gharizadeh; Ma Luo; Francis A Plummer; Joshua Kimani; Mary Carrington; Derek Middleton; Raja Rajalingam; Meral Beksac; Steven G E Marsh; Martin Maiers; Lisbeth A Guethlein; Sofia Tavoularis; Ann-Margaret Little; Richard E Green; Paul J Norman; Peter Parham
Journal:  Science       Date:  2011-08-25       Impact factor: 47.728

Review 5.  Rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Iain B McInnes
Journal:  Lancet       Date:  2016-05-03       Impact factor: 79.321

Review 6.  Inflammasomes: mechanism of action, role in disease, and therapeutics.

Authors:  Haitao Guo; Justin B Callaway; Jenny P-Y Ting
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

Review 7.  Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.

Authors:  Stefan Siebert; Alexander Tsoukas; Jamie Robertson; Iain McInnes
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 8.  New therapies for treatment of rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Marcus Koeller; Michael H Weisman; Paul Emery
Journal:  Lancet       Date:  2007-12-01       Impact factor: 79.321

Review 9.  Evolving concepts of rheumatoid arthritis.

Authors:  Gary S Firestein
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 10.  Inflammasome activation and assembly at a glance.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  J Cell Sci       Date:  2017-12-01       Impact factor: 5.285

View more
  4 in total

Review 1.  Inflammasomes and the IL-1 Family in Bone Homeostasis and Disease.

Authors:  Hsu-Wen Tseng; Selwin Gabriel Samuel; Kate Schroder; Jean-Pierre Lévesque; Kylie A Alexander
Journal:  Curr Osteoporos Rep       Date:  2022-05-14       Impact factor: 5.163

Review 2.  Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis.

Authors:  Qi Jiang; Xin Wang; Enyu Huang; Qiao Wang; Chengping Wen; Guocan Yang; Liwei Lu; Dawei Cui
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

3.  A Novel Long-Noncoding RNA LncZFAS1 Prevents MPP+-Induced Neuroinflammation Through MIB1 Activation.

Authors:  Ziman Zhu; Peiling Huang; Ruifeng Sun; Xiaoling Li; Wenshan Li; Weijun Gong
Journal:  Mol Neurobiol       Date:  2021-11-13       Impact factor: 5.682

Review 4.  Advances in the therapeutic application and pharmacological properties of kinsenoside against inflammation and oxidative stress-induced disorders.

Authors:  Li Lu; Yuan Xiong; Ze Lin; Xiangyu Chu; Adriana C Panayi; Yiqiang Hu; Juan Zhou; Bobin Mi; Guohui Liu
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.